Paper Details

  1. Home
  2. Paper Details

Advances in pneumococcal vaccines: advantages for infants and children.

Author: BernatonieneJolanta, FinnAdam

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Pneumococcal vaccines are important for protecting children from bacterial infections. The 23-valent pneumococcal polysaccharide vaccine is effective in older children but not in infants, while pneumococcal conjugate vaccines are effective in infants but have limited coverage. More research is needed to develop better vaccines with wider coverage and lower costs.
Paper Details　
Original Abstract of the Article :
The introduction of Haemophilus influenzae type b (Hib) vaccine into the universal immunisation schedules of many industrialised countries and the subsequent remarkable decline in the incidence of invasive Hib disease has further highlighted the impact of invasive pneumococcal diseases. Streptococcu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2165/00003495-200565020-00005

データ提供：米国国立医学図書館（NLM）

Pneumococcal Vaccines: Protecting Infants and Children

Pneumococcal disease, caused by the bacterium Streptococcus pneumoniae, remains a significant threat to infants and children. This research explores the advancements in pneumococcal vaccines, highlighting the importance of vaccination in protecting vulnerable populations. The study examines the effectiveness of both polysaccharide and conjugate vaccines in preventing pneumococcal disease, and discusses the ongoing development of new vaccines with broader protection.

A Shield Against Disease: Pneumococcal Vaccines

The study underscores the effectiveness of pneumococcal vaccines in preventing invasive pneumococcal disease in infants and young children. Imagine a protective shield against the harsh elements of the desert, guarding travelers from harm. Pneumococcal vaccines provide a similar protective shield against this potentially deadly disease, safeguarding the health of our most vulnerable populations.

A Promise for a Healthier Future

This research emphasizes the crucial role of vaccination in protecting children from pneumococcal disease. Just as a camel relies on its strength and resilience to navigate the desert, children depend on the protection provided by vaccines to stay healthy and thrive. This study highlights the importance of continuing research and development efforts to create even more effective pneumococcal vaccines, ensuring the safety and well-being of future generations.

Dr.Camel's Conclusion

This research showcases the remarkable advancements in pneumococcal vaccines, offering a powerful tool for protecting children from a serious and potentially life-threatening disease. Like a caravan traversing the desert, we must continue to invest in research and development to create even more effective vaccines and ensure the health and well-being of future generations.

Date :
  1. Date Completed 2005-04-29
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

15631543

DOI: Digital Object Identifier

10.2165/00003495-200565020-00005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.